1. 1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study
- Author
-
Sabine Fiala-Buskies, Kirhan Ozgurdal, Catherine Frenette, H.Y. Lim, S. Qin, Yoon Jun Kim, Richard S. Finn, Gianluca Masi, Masatoshi Kudo, Hong Zebger-Gong, Masafumi Ikeda, René Gerolami, Philippe Merle, Kazushi Numata, H.-J. Klümpen, Masayuki Kurosaki, Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Assistance Publique - Hôpitaux de Marseille (APHM), Service d'Hépatologie et de Gastroentérologie [Lyon], and Hospices Civils de Lyon (HCL)
- Subjects
Oncology ,medicine.medical_specialty ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Internal medicine ,Regorafenib ,medicine ,In patient ,[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology ,Dosing ,ComputingMilieux_MISCELLANEOUS ,030304 developmental biology ,0303 health sciences ,[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,business.industry ,Hematology ,medicine.disease ,Interim analysis ,[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,3. Good health ,chemistry ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,Observational study ,business - Abstract
International audience
- Published
- 2020
- Full Text
- View/download PDF